Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $44,478 - $76,248
-105,900 Reduced 29.66%
251,200 $158,000
Q3 2023

Nov 14, 2023

BUY
$0.6 - $1.53 $76,920 - $196,146
128,200 Added 56.01%
357,100 $214,000
Q2 2023

Aug 11, 2023

SELL
$1.05 - $1.63 $10,605 - $16,463
-10,100 Reduced 4.23%
228,900 $258,000
Q1 2023

May 16, 2023

SELL
$1.2 - $2.73 $198,600 - $451,815
-165,500 Reduced 40.91%
239,000 $322,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $581,571 - $1.23 Million
-340,100 Reduced 45.68%
404,500 $752,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $687,040 - $3.12 Million
361,600 Added 94.41%
744,600 $1.83 Million
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $558,912 - $2.36 Million
-262,400 Reduced 40.66%
383,000 $935,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $2.31 Million - $5.73 Million
-367,500 Reduced 36.28%
645,400 $5.14 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $7.28 Million - $14.2 Million
-495,500 Reduced 32.85%
1,012,900 $15.5 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $7.08 Million - $9.78 Million
-291,200 Reduced 16.18%
1,508,400 $42.9 Million
Q2 2021

Aug 11, 2021

BUY
$26.09 - $40.4 $18.1 Million - $28.1 Million
694,600 Added 62.86%
1,799,600 $60.7 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $809,970 - $1.39 Million
-24,500 Reduced 2.17%
1,105,000 $42.2 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $3.21 Million - $4.71 Million
82,000 Added 7.83%
1,129,500 $47.2 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $15.6 Million - $24.5 Million
547,500 Added 109.5%
1,047,500 $45.4 Million
Q2 2020

Aug 14, 2020

SELL
$11.71 - $30.29 $2.22 Million - $5.73 Million
-189,300 Reduced 27.46%
500,000 $15.1 Million
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $3.35 Million - $12.1 Million
438,900 Added 175.28%
689,300 $9.42 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $988,316 - $1.35 Million
-65,800 Reduced 20.81%
250,400 $4.04 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $818,090 - $1.19 Million
43,400 Added 15.91%
316,200 $6.09 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $378,666 - $572,686
21,800 Added 8.69%
272,800 $6.41 Million
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $1.99 Million - $4.82 Million
187,100 Added 292.8%
251,000 $5.88 Million
Q4 2018

Feb 14, 2019

SELL
$9.26 - $16.38 $202,794 - $358,722
-21,900 Reduced 25.52%
63,900 $707,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $153,816 - $373,524
20,400 Added 31.19%
85,800 $1.44 Million
Q2 2018

Aug 14, 2018

SELL
$4.87 - $8.42 $178,729 - $309,014
-36,700 Reduced 35.95%
65,400 $481,000
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $136,479 - $292,455
29,100 Added 39.86%
102,100 $479,000
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $287,676 - $365,634
36,600 Added 100.55%
73,000 $663,000
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $323,596 - $378,560
36,400
36,400 $341,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.